RENOVACOR INC NYSE MKT LLC:RCOR Renovacor is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Renovacor’s therapeutic focus is initially on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.

Location: | Website: renovacor.com | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing